Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

US Patent 9200090 · Granted Dec 1, 2015

Estimated economic value: $836,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for the prevention and treatment of medical disorders and uses thereof2025
Compounds for the prevention and treatment of medical disorders and uses thereof2023
Compounds for the prevention and treatment of diseases and the use thereof2023
Low-profile keysets and input devices2022
Methods for treatment of arthritis2022
Methods for treatment of arthritis2022
Computing device display management2021
Composition of novel carbohydrate drug for treatment of human diseases2020
Composition of novel carbohydrate drug for treatment of human diseases2020
Low-profile input devices2020
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies2020
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies2020